-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research.pdf
March 01, 2018 - Efficacy and safety of lacosamide in painful
diabetic neuropathy. … Duloxetine vs. placebo in patients with
painful diabetic neuropathy. … Treatment of painful diabetic neuropathy
with topical capsaicin. … Treatment of painful diabetic neuropathy
with capsaicin 0.075%. … Mexiletine for treatment of chronic painful
diabetic neuropathy.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-prevalence_research.pdf
February 01, 2011 - Prevalence of diabetes, diabetic foot ulcer, and lower
extremity amputation among Medicare beneficiaries … ,
2006 to 2008
Diabetic Foot Ulcers Data Points #1
The prevalence of diabetes in
the Medicare population … Levin and O’Neal’s The Diabetic Foot.
6th ed. St. Louis: Mosby; 2001. pp.13-32.
3. … The diabetic foot: grand overview, epidemiology, and pathogen-
esis. … Diabetic Foot Ulcers.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-diabetes-rapid-research.pdf
November 01, 2024 - COD are significantly more common and more severe in diabetic patients,5 with particular
associations … This suggests that
integrating periodontal therapy into routine care for diabetic patients could be … and
Non-Diabetic Patients With Chronic
Periodontitis. … and type 2 diabetic
periodontitis patients. … and non-diabetic
subjects with periodontitis: A
cohort study.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-drugs-utilization_research.pdf
March 01, 2011 - Approximately 37 percent of diabetic
beneficiaries had a claim for a
biguanide in 2009. … Yearly prevalence (%) of antidiabetic drug class utilization among
diabetic Medicare beneficiaries … Among diabetic beneficiaries who received at least one prescription for an
antidiabetic medication, … in around 0.14 percent of diabetic benefi-
ciaries. … Beneficiaries included both
incident and prevalent users of anti-
diabetic agents.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
January 01, 2015 - Diabetic
retinopathy and diabetic macular edema:
pathophysiology, screening, and novel therapies. … Fluocinolone
acetonide implantable device for diabetic
retinopathy. … Association of vitreous inflammatory factors
with diabetic macular edema. … Diabetic macular edema (DME). [internet]. … Corticosteroids for diabetic macular
edema. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
January 01, 2016 - Diabetic
retinopathy and diabetic macular edema:
pathophysiology, screening, and novel therapies. … Fluocinolone
acetonide implantable device for diabetic
retinopathy. … Diabetic macular edema (DME). [internet]. … Corticosteroids for diabetic macular
edema. [internet]. … Diabetic Retinopathy Clinical Research Network.
-
effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
January 01, 2012 - Overall high-impact potential: ranibizumab (Lucentis) for treatment of diabetic
macular edema ..... … *Ranibizumab (Lucentis) for treatment of diabetic macular edema Moderately high
11. … Diabetic
macular edema: update and treatment options. In:
Medscape Education [internet]. … ILUVIEN for diabetic macular edema (DME).
[internet]. … Ranibizumab dose
comparison for the treatment of diabetic macular
edema.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
January 01, 2016 - Diabetic macular edema (DME). [internet]. … Corticosteroids for diabetic macular
edema. [internet]. … Diabetic
retinopathy and diabetic macular edema:
pathophysiology, screening, and novel therapies. … Fluocinolone
acetonide implantable device for diabetic
retinopathy. … Diabetic Retinopathy Clinical Research Network.
-
effectivehealthcare.ahrq.gov/products/diabetes-oral-medicines-nephropathy/research
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
December 01, 2015 - Bariatric surgery as metabolic surgery for
diabetic patients. … Diabetic
retinopathy and diabetic macular edema:
pathophysiology, screening, and novel therapies. … Fluocinolone
acetonide implantable device for diabetic
retinopathy. … Association of vitreous inflammatory factors
with diabetic macular edema. … Corticosteroids for diabetic macular
edema. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research-protocol.pdf
September 01, 2016 - Effectiveness of Treatments Options for the Prevention of Complications and Treatment of Symptoms of Diabetic … Effectiveness of Treatments Options for the Prevention of Complications
and Treatment of Symptoms of Diabetic … Effectiveness of Treatments Options for the Preven-
tion of Complications and Treatment of Symptoms of Diabetic … antidepressants, antiepileptics, and topical and subcutaneous treatments) to improve the
symptoms of diabetic … [STUDY-TYPES] AND NOT ("not yet recruiting" OR "terminat-
ed" OR "withdrawn") [OVERALL-STATUS] AND diabetic
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1506.pdf
June 01, 2015 - Many
diabetic patients have poor control of their blood sugar level. … Bariatric surgery as metabolic surgery for
diabetic patients. … Diabetic
retinopathy and diabetic macular edema:
pathophysiology, screening, and novel therapies. … Fluocinolone
acetonide implantable device for diabetic
retinopathy. … Corticosteroids for diabetic macular
edema. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
September 26, 2014 - Diabetic
retinopathy and diabetic macular edema:
pathophysiology, screening, and novel therapies. … Fluocinolone
acetonide implantable device for diabetic
retinopathy. … Association
of vitreous inflammatory factors with diabetic
macular edema. … Diabetic macular edema (DME). [internet]. … Corticosteroids for diabetic macular
edema. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_clinician.pdf
November 01, 2016 - relaxation or stress
reduction; blood glucose regulation; medication adherence;
or self-monitoring for diabetic … medication use, glucose
monitoring [when necessary], prevention and detection of
acute and chronic diabetic … structured dietary intervention (related to weight
loss, glycemic control, or reducing the risk for diabetic
-
effectivehealthcare.ahrq.gov/products/diabetes-foot-ulcer-amputation-economics/research
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0855-170515.pdf
April 28, 2017 - of mHealth technologies for diabetes could
address uncertainty about mHealth’s impact on improving diabetic … Approximately 86 million Americans are pre-diabetic,
and 29 million suffer from a form of Diabetes Mellitus … Diabetic medicine : a journal of the British Diabetic Association. … Implementation of Foot Thermometry and SMS
and Voice Messaging to Prevent Diabetic Foot Ulcer. … Approximately
86 million Americans are pre-diabetic, and 29 million suffer from a form of
Diabetes
-
effectivehealthcare.ahrq.gov/sites/default/files/tnd-0855-170515.pdf
April 28, 2017 - of mHealth technologies for diabetes could
address uncertainty about mHealth’s impact on improving diabetic … Approximately 86 million Americans are pre-diabetic,
and 29 million suffer from a form of Diabetes Mellitus … Diabetic medicine : a journal of the British Diabetic Association. … Implementation of Foot Thermometry and SMS
and Voice Messaging to Prevent Diabetic Foot Ulcer. … Approximately
86 million Americans are pre-diabetic, and 29 million suffer from a form of
Diabetes
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_disposition-comments.pdf
August 01, 2012 - Diabetic
nephropathy is a rapidly growing problem and its attendant
association with cardiovascular … patients and non-diabetic
patients. … For
example, screening for macroalbuminuria in diabetic patients
and for eGFR in non-diabetic, high-risk … It is unclear whether screening non-diabetic populations for
CKD is beneficial. … For non-diabetic CKD patients, antihypertensive treatment is
7. We appreciate this comment.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-3-nonopioid-pharm-chronic-pain.pdf
July 01, 2022 - A
randomized control trial of duloxetine and
gabapentin in painful diabetic neuropathy. … A randomized controlled trial of
duloxetine in diabetic peripheral neuropathic
pain. … Duloxetine vs. placebo in patients with
painful diabetic neuropathy. … A
randomized control trial of duloxetine and
gabapentin in painful diabetic neuropathy. … Management of diabetic neuropathic
refractory pain.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/bariatric-surgery_research.pdf
June 01, 2010 - decrease)
Count at 6
months (and
% decrease)
Count at 12
months(and
% decrease)
Diabetes Diabetic … Patients Only:
1.1 [0.96-1.2] 0.45 (58) 0.35 (68) 0.27 (75)
Anti-
hypertensives
Diabetic
Patients … :
1.0 [0.91-1.1] 0.66 (34) 0.61 (39) 0.55 (45)
Non-diabetic
Patients:
0.72 [0.67-0.78] 0.41 (43 … (and
% decrease)
Probability of
Medication at
12 Months
(and %
decrease)
Lipid-lowering Diabetic … Patients:
0.34 [0.33-0.37] 0.15 (55) 0.16 (52) 0.15 (55)
Non-diabetic
Patients:
0.16 [0.14-0.18